| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $12.8M | -21.9% | +48.9% |
| SG&A Expense | $3.0M | -35.7% | -17.5% |
| Operating Income | -$15.8M | +24.9% | -29.2% |
| Net Income | -$14.3M | +28.3% | -36.0% |
| EPS (Basic) | -$0.08 | +42.9% | +0.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $46.2M | +102.2% | +25.6% |
| Short-term Investments | $173.7M | +122.4% | +76.1% |
| Current Assets | $221.1M | +108.2% | +56.7% |
| Total Assets | $231.3M | +98.2% | +55.1% |
| Current Liabilities | $12.4M | -10.4% | +180.0% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$35.9M | — | — |
| Capital Expenditures | $25K | — | — |
| Investing Cash Flow | -$89.9M | — | — |
| Financing Cash Flow | $128.5M | — | — |
| Free Cash Flow | -$35.9M | — | — |
| $21.6M |
| -7.9% |
| +101.3% |
| Stockholders' Equity | $209.6M | +124.9% | +51.5% |